Investor Relations
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Latest Financial Results
Q1 2022
Quarter Ended Mar 31, 2022
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
Canada
T: (250) 327 8675
ir@kanebiotech.com
Investor Relations
Jonathan Paterson
Managing Partner
263 Tresser Blvd 9th Fl
Stamford, CT 06901
USA
T: (203) 862 0492
jonathan.paterson@harboraccessllc.com
Kane Biotech Inc.
Nicole Sendey
Investor Relations & Public Relations
T: 250-327-8675
nsendey@kanebiotech.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1